Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Abbott Laboratories Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

$3.1 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $1.71 Million - $2.5 Million	-27,255 Closed	0 $0
Q4 2019 Jan 17, 2020	SELL	$78.51 - $87.4 $7.06 Million - $7.86 Million	-89,920 Reduced 76.74%	27,255 $2.37 Million
Q3 2019 Oct 29, 2019	BUY	$81.84 - $88.74 $4.14 Million - $4.49 Million	50,594 Added 75.99%	117,175 $9.55 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $4.41 Million - $5.33 Million	66,581 New	66,581 $5.29 Million
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $10 Million - $11.4 Million	-152,985 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$60.81 - $73.36 $1.57 Million - $1.9 Million	25,835 Added 20.32%	152,985 $11.1 Million
Q2 2018 Jul 17, 2018	SELL	$57.57 - $63.54 $1.69 Million - $1.86 Million	-29,328 Reduced 18.74%	127,150 $7.86 Million
Q1 2018 May 02, 2018	SELL	$56.27 - $63.62 $6.65 Million - $7.52 Million	-118,162 Reduced 43.02%	156,478 $9.23 Million
Q4 2017 Jan 26, 2018	BUY	$53.68 - $57.47 $9.87 Million - $10.6 Million	183,911 Added 202.7%	274,640 $15.9 Million
Q3 2017 Nov 06, 2017	BUY	$48.06 - $53.64 $4.36 Million - $4.87 Million	90,729	90,729 $4.88 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.3 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.8 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.54 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.12 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Account